CES1 and hepatocellular carcinoma: Interestingly, a correlation analysis using the KM plotter (kmplot.com) demonstrated a trend toward a negative association between the levels of CES1 and survival probability in HCC patients treated with sorafenib (Supplemental Figure 6E), suggesting a potential synergistic effect between CES1 inhibition and sorafenib treatment.